Combining molecular targeted agents with radiation therapy for malignant gliomas.

Onco Targets Ther · 2013 · PMC3745290 · PMID 23966794

Europe PMC DOI

hedged sentence

0.2135

closest p · 4.3× alpha

0.2135

boldest claim

The sentences

did not reach statistical significanceP = 0.2135not close (p > 0.1)

However, interim results for overall survival did not reach statistical significance (hazard ratio = 0.89; P = 0.2135).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.